Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting

Arterioscler Thromb Vasc Biol. 2024 Mar;44(3):533-544. doi: 10.1161/ATVBAHA.123.318286. Epub 2024 Jan 18.

Abstract

Both hyperlipidemia and thrombosis contribute to the risks of atherosclerotic cardiovascular diseases, which are the leading cause of death and reduced quality of life in survivors worldwide. The accumulation of lipid-rich plaques on arterial walls eventually leads to the rupture or erosion of vulnerable lesions, triggering excessive blood clotting and leading to adverse thrombotic events. Lipoproteins are highly dynamic particles that circulate in blood, carry insoluble lipids, and are associated with proteins, many of which are involved in blood clotting. A growing body of evidence suggests a reciprocal regulatory relationship between blood clotting and lipid metabolism. In this review article, we summarize the observations that lipoproteins and lipids impact the hemostatic system, and the clotting-related proteins influence lipid metabolism. We also highlight the gaps that need to be filled in this area of research.

Keywords: cardiovascular diseases; coagulation; fibrin; fibrinolysis; lipid; lipoproteins.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Atherosclerosis* / pathology
  • Blood Coagulation
  • Blood Coagulation Factors
  • Fibrinolysis
  • Humans
  • Lipoproteins
  • Quality of Life
  • Thrombosis*

Substances

  • Blood Coagulation Factors
  • Lipoproteins